personkort Berit Kriström, Enheten f Pediatrik, Umeå Universitet, 90185 Umeå

Basuppgifter

namn:
Berit Kriström
arbetsplats:
Enheten f Pediatrik, Umeå Universitet, 90185 Umeå
yrkestitel:
Universitetslektor/Överläkare, Med dr, barnendokrinolog
e-post

Arbete

arbetsplats:
Enheten f Pediatrik, Umeå Universitet, 90185 Umeå
telefon:
+46-90-785 0000
arbetsgivarkategori:
Universitet/Högskola
adress:
Umeå Universitet
postadress:
901 85 Umeå
land:
Sverige

CV

Article - Peer reviewed scientific (22)

  1. Prediction of the growth response of short prepubertal children treated with growth hormone. Swedish Paediatric Study Group for GH treatment.
    Kriström B, Karlberg J, Albertsson-Wikland K.
    Acta Paediatr. 1995:84(1):51-7.
    [Links: PMID: 7734899][Source: PubMed®]
    Web of Science® citations 27
  2. Improved final height in girls with Turner's syndrome treated with growth hormone and oxandrolone.
    Nilsson K O, Albertsson-Wikland K, Alm J, Aronson S, Gustafsson J, Hagenäs L, Häger A, Ivarsson S A, Karlberg J, Kriström B, Marcus C, Moell C, Ritzen M, Tuvemo T, Wattsgård C, Westgren U, Westphal O, Aman J.
    J Clin Endocrinol Metab. 1996:81(2):635-40.
    [Links: PMID: 8636281][Source: PubMed®]
    Web of Science® citations 84
  3. Leptin levels are strongly correlated with those of GH-binding protein in prepubertal children.
    Bjarnason R, Boguszewski M, Dahlgren J, Gelander L, Kriström B, Rosberg S, Carlsson B, Albertsson-Wikland K, Carlsson L M.
    Eur J Endocrinol. 1997:137(1):68-73.
    [Links: PMID: 9242204][Source: PubMed®]
    Web of Science® citations 28
  4. Growth response to growth hormone (GH) treatment relates to serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 in short children with various GH secretion capacities. Swedish Study Group for Growth Hormone Treatment.
    Kriström B, Jansson C, Rosberg S, Albertsson-Wikland K.
    J Clin Endocrinol Metab. 1997:82(9):2889-98.
    [Links: PMID: 9284715][Source: PubMed®]
    Web of Science® citations 62
  5. Short-term changes in serum leptin levels provide a strong metabolic marker for the growth response to growth hormone treatment in children. Swedish Study Group for Growth Hormone Treatment.
    Kriström B, Carlsson B, Rosberg S, Carlsson L M, Albertsson-Wikland K.
    J Clin Endocrinol Metab. 1998:83(8):2735-41.
    [Links: PMID: 9709940][Source: PubMed®]
    Web of Science® citations 38
  6. Effect of growth hormone (GH) during puberty in GH-deficient children: preliminary results from an ongoing randomized trial with different dose regimens.
    Albertsson Wikland K, Alm F, Aronsson S, Gustafsson J, Hagenäs L, Häger A, Ivarsson S, Kriström B, Marcus C, Moëll C, Nilsson K O, Ritzén M, Tuvemo T, Westgren U, Westphal O, Aman J.
    Acta Paediatr Suppl 1999:88(428):80-4.
    [Links: PMID: 10102059][Source: PubMed®]
  7. Prevalence of coeliac disease in Turner syndrome.
    Ivarsson S A, Carlsson A, Bredberg A, Alm J, Aronsson S, Gustafsson J, Hagenäs L, Häger A, Kriström B, Marcus C, Moëll C, Nilsson K O, Tuvemo T, Westphal O, Albertsson-Wikland K, Aman J.
    Acta Paediatr. 1999:88(9):933-6.
    [Links: PMID: 10519331][Source: PubMed®]
    Web of Science® citations 37
  8. Validated multivariate models predicting the growth response to GH treatment in individual short children with a broad range in GH secretion capacities.
    Wikland K A, Kriström B, Rosberg S, Svensson B, Nierop A F.
    Pediatr Res. 2000:48(4):475-84.
    [Links: PMID: 11004238][Source: PubMed®]
    Web of Science® citations 29
  9. Effect of spontaneous GH secretion and the GH sampling period on the accuracy of models for predicting growth responses to GH treatment.
    Kriström B, Löfqvist C, Rosberg S, Albertsson Wikland K.
    J Clin Endocrinol Metab. 2001:86(10):4963-4.
    [Links: PMID: 11600570][Source: PubMed®]
    Web of Science® citations 10
  10. Growth prediction models, concept and use.
    Kriström Berit, Wikland Kerstin Albertsson.
    Horm Res. 2002:57:66-70.
    [Links: PMID: 12065931][Source: PubMed®]
    Web of Science® citations 6
  11. Cartilage oligomeric matrix protein increases in serum after the start of growth hormone treatment in prepubertal children.
    Bjarnason R, Andersson B, Kim H S, Olsson B, Swolin-Eide D, Wickelgren R, Kriström B, Carlsson B, Albertsson-Wikland K, Carlsson L M S.
    J Clin Endocrinol Metab. 2004:89(10):5156-60.
    [Links: PMID: 15472220 | DOI länk][Source: PubMed®]
    Web of Science® citations 5
  12. Final height after combined growth hormone and GnRH analogue treatment in adopted girls with early puberty.
    Tuvemo T, Jonsson B, Gustafsson J, Albertsson-Wikland K, Aronson A S, Häger A, Ivarson S, Kriström B, Marcus C, Nilsson K O, Westgren U, Westphal O, Aman J, Proos L A.
    Acta Paediatr. 2004:93(11):1456-62.
    [Links: PMID: 15513572 | DOI länk][Source: PubMed®]
    Web of Science® citations 11
  13. Models predicting the growth response to growth hormone treatment in short children independent of GH status, birth size and gestational age.
    Dahlgren Jovanna, Kriström Berit, Niklasson Aimon, Nierop Andreas F M, Rosberg Sten, Albertsson-Wikland Kerstin.
    BMC medical informatics and decision making 2007:7:40.
    [Links: PMID: 18076760 | DOI länk][Source: PubMed®]
    Web of Science® citations 15
  14. Dose-dependent effect of growth hormone on final height in children with short stature without growth hormone deficiency.
    Albertsson-Wikland Kerstin, Aronson A Stefan, Gustafsson Jan, Hagenäs Lars, Ivarsson Sten A, Jonsson Björn, Kriström Berit, Marcus Claude, Nilsson Karl Olof, Ritzén E Martin, Tuvemo Torsten, Westphal Otto, Aman Jan.
    J Clin Endocrinol Metab. 2008:93(11):4342-50.
    [Links: PMID: 18728172 | DOI länk][Source: PubMed®]
    Web of Science® citations 28
  15. Growth hormone (GH) dosing during catch-up growth guided by individual responsiveness decreases growth response variability in prepubertal children with GH deficiency or idiopathic short stature.
    Kriström Berit, Aronson A Stefan, Dahlgren Jovanna, Gustafsson Jan, Halldin Maria, Ivarsson Sten A, Nilsson Nils-Osten, Svensson Johan, Tuvemo Torsten, Albertsson-Wikland Kerstin.
    J Clin Endocrinol Metab. 2009:94(2):483-90.
    [Links: PMID: 19001519 | DOI länk][Source: PubMed®]
    Web of Science® citations 17
  16. A novel mutation in the LIM homeobox 3 gene is responsible for combined pituitary hormone deficiency, hearing impairment, and vertebral malformations.
    Kriström Berit, Zdunek Anna-Maija, Rydh Anders, Jonsson Håkan, Sehlin Petra, Escher Stefan A.
    J Clin Endocrinol Metab. 2009:94(4):1154-61.
    [Links: PMID: 19126629 | DOI länk][Source: PubMed®]
    Web of Science® citations 17
  17. The first-year growth response to growth hormone treatment predicts the long-term prepubertal growth response in children.
    Kriström Berit, Dahlgren Jovanna, Niklasson Aimon, Nierop Andreas F M, Albertsson-Wikland Kerstin.
    BMC medical informatics and decision making 2009:9:1.
    [Links: PMID: 19138407 | DOI länk][Source: PubMed®]
    Web of Science® citations 6
  18. Decrease in adiponectin levels correlates to growth response in growth hormone-treated children.
    Andersson B, Carlsson L M S, Carlsson B, Albertsson-Wikland K, Bjarnason R;
    Swedish Study Group for Growth Hormone Treatment.
    Horm Res. 2009:71(4):213-8.
    [Links: PMID: 19258713 | DOI länk][Source: PubMed®]
    Web of Science® citations 3
  19. Metabolic outcome of GH treatment in prepubertal short children with and without classical GH-deficiency.
    Decker Ralph, Albertsson-Wikland Kerstin, Kriström Berit, Nierop Andreas F M, Gustafsson Jan, Bosaeus Ingvar, Fors Hans, Hochberg Ze'ev, Dahlgren Jovanna.
    Clinical endocrinology 2010
    [Links: PMID: 20455890 | DOI länk][Source: PubMed®]
    Web of Science® citations 2
  20. A comparison of different definitions of growth response in short prepubertal children treated with growth hormone.
    Bang P, Bjerknes R, Dahlgren J, Dunkel L, Gustafsson J, Juul A, Kriström B, Tapanainen P, Aberg V.
    Horm Res Paediatr 2011:75(5):335-45.
    [Links: PMID: 21228552 | DOI länk][Source: PubMed®]
  21. Long-term response to GH therapy in short children with a delayed infancy-childhood transition (DICT).
    Albertsson-Wikland Kerstin, Kriström Berit, Jonsson Björn, Hochberg Ze'ev.
    Pediatr Res. 2011:69(6):504-10.
    [Links: PMID: 21297523 | DOI länk][Source: PubMed®]
  22. Improvements in behaviour and self-esteem following growth hormone treatment in short prepubertal children.
    Chaplin John Eric, Kriström Berit, Jonsson Björn, Hägglöf Bruno, Tuvemo Torsten, Aronson A Stefan, Dahlgren Jovanna, Albertsson-Wikland Kerstin.
    Horm Res Paediatr 2011:75(4):291-303.
    [Links: PMID: 21304250 | DOI länk][Source: PubMed®]

Book Chapter (4)

  1. Timing of oestrogen therapy in girls with Turner syndrome: the Swedish experiences and a review.
    Nilsson K-O, Albertsson-Wikland Kerstin, Alm J, Aronson S, Gustafsson J, Hagenäs L, Häger A, Ivarsson SA, Kriström B, Marcus C, Moell C, Ritzén M, Tuvemo T, Westgren U, Westphal O, Åman J.
    Otimizing Health Care for Turner Patients in the 21st Century. Amsterdam, The Netherlands: Elsevier; 2000, pp 185-97.
    [Source: User]
  2. Turner Syndrome: Management and research in a life-span perspective.
    Bryman Inger, Barrenäs M-L, Landin-Wilhelmsen K, Wide Boman U, Kriström B, Albertsson-Wikland K.
    Paediatric and Adolescent Gynaecology. Amsterdam, Netherlands: Elsevier Health Sciences; 2003, pp 181-90. ISBN 9780444513601.
    [Source: User]
  3. The role of the gynecologist in the multidisciplinary management of girls and woman with Turner syndrome.
    Jansson P-O, Barrenäs M-L, Kriström B, Hansson C, Möller A, Wilhelmsen-Landin Kerstin, Albertsson-Wikland Kerstin.
    The multidisciplinary approach to the management of paediatric and adolescent gynaecology.. Cambridge, UK: Cambridge University Press; 2004, pp 242-52.
    [Source: User]
  4. Psychological Importance to the Child of Growth Hormone Replacement.
    Chaplin John Eric, Dahlgren Jovanna, Kriström Berit, Albertsson Wikland Kerstin.
    The Somatotrophic Axis in Brain Function. Uppsala, Sweden: Elsevier; 2006, pp 249-66. ISBN 978-0-12-088484-1.
    [Source: User]

Report (1)

  1. Nationella kvalitetsregistret för barn på tillväxthormonbehandling.
    Albertsson-Wikland Kerstin, Hagenäs L, Westgren U, Kriström B, Svensson J, Tuvemo T.
    2007.
    [Source: User]

Article - Other scientific (3)

  1. Long-term results of combination treatment with Growth hormone, Oxandrolone and Ethinyloestradiol in girls with Turner syndrome.
    Nilsson K, Albertsson-Wikland Kerstin, Aronson S, Gustafsson J, Hagenäs L, Häger A, Ivarsson S, Karlberg J, Kriström B, Marcus C, Moell C, Ritzen EM, Tuvemo T, Wattsgård C, Westgren U, Westphal O, Åman J.
    Excerpta Medica ICS 1993:1014:303-10.
    [Source: User]
  2. Growth promoting treatment in girls with Turner syndrome: Final height results according to three Turner syndrome growth standards.
    Olsson KO, Albertsson-Wikland Kerstin, Alm J, Aronsson S, Gustafsson J, Hagenäs L, Häger A, Ivarsson SA, Karlberg J, Kriström Berit, Marcus C, Moell C, Ritzen M, Tuvemo T, Wattsgård C, Westgren U, Westphal O, Åman J.
    Excerpta Medica ICS 1995:89-94.
    [Source: User]
  3. High prevalence of celiac disease in Turner's syndrome.
    Ivarsson S-A, Carlsson A, Bredberg A, Alm J, Aronsson S, Gustafsson J, Hagenäs I, Häger A, Kriström B, Marcus C, Nilsson K, Tuvemo T, Westphal O, Albertsson-Wikland Kerstin, Åman J.
    Review Series Pediatrics 2001:2(01):12-4.
    [Source: User]

Position today:
"Högskolelektor" 2005< Dep of Pediatrics, Umeå University, Umeå
Consultant in Pediatric endocrinology 2005< , Umeå Universityhospital, Umeå

Education and Degrees:
PhD Degree in paediatric endocrinology 4th June 1999
Subspecialty in paediatric endocrinology and diabetes
Licensed as specialist in paediatrics 25th November 1980
Licensed to practice medicine 15th March 1976
University Medical Degree (MD) 28th June 1974

Professional Positions after Specialist Training:
University positions:
Locus as Associate Professor (full time) in addition to my consultant physician position, Umeå University, 14th Feb - 31st Aug 2000 and ongoing from 1st Febr 2005.
Research position, Göteborg Pediatric Growth Research Centre, half time 1st Jan 2002 – 31st Jan 2005.
Full PhD-scholarship, Umeå University, Dep of Paediatrics Nov 1995 - Dec 1999.

Clinical:
Consultant physician in paediatric endocrinology, Umeå University hospital, Umeå, Full time 1990 - Sept 2000, part time since 1st Oct 2000.
Consultant physician in paediatric endocrinology, Queen Silvias Childrens Hospital, Göteborg, part time 1st Oct 2000 – 31st July 2005.
Consultant physician in general paediatrics, Örnsköldsvik county hospital, Nov 1981 - 1990.
Specialist position (Senior registrar), Umeå University hospital, Nov 1980 -Oct 1981.
Arbetsgivare Anställningsgrad BörjadeSlutade
Landsting - Västerbottens läns landsting - Specialiserad vård - Norrlands Universitetssjukhus
 100% 1980 1981
Landsting - Landstinget Västernorrland - Specialiserad vård - Specialiserad vård Örnsköldsvik
 100% 1981 1990
Landsting - Västerbottens läns landsting - Specialiserad vård - Norrlands Universitetssjukhus
 100% 1990 1995
Statligt - Universitet - Umeå Universitet - Medicinsk fakultet - Klinisk vetenskap - Pediatrik
 100% 1995 1999
Landsting - Västerbottens läns landsting - Specialiserad vård - Norrlands Universitetssjukhus
 30% 1995 1999
Landsting - Västra Götalandsregionen - Specialiserad vård - Sahlgrenska Universitetssjukhuset, Område 1 - Barnmedicin
 50% 2000 2005
Statligt - Universitet - Göteborgs universitet - Sahlgrenska akademin - Institutionen för kvinnors och barns hälsa, Avdelningen för pediatrik [1991 - 2005]
 50% 2002 2005
Landsting - Västerbottens läns landsting - Specialiserad vård - Norrlands Universitetssjukhus
 100% 2005

Administration:
Chairwomen for the Swedish National Committee for growth disturbances and GH treatment since 2005.
Responsible for the pediatric endocrine team 1990<.
Staff planning, Dep of Paediatrics, Umeå 1990-1993.
Tutor for residents in pediatrics, Örnsköldsvik and Umeå.
Organising female leadership issues, Umeå 1991-1992.
Participating in continuos medical education planning, all departments, Örnsköldsvik hospital, 1988-89.
Head of Dep of Pediatrics, Örnsköldsvik (2 years), including all staff planning (9 years).

Teaching:
Program director for the last (11th) semester for Medical students with a new curriculum (U2007) incl. teaching in 3 additional hospitals in the Northern region of Sweden, Jan 2009 – ff.
Tutor at the ’ESPE Pan-African Fellowship Programme’ in Nairobi, January 2009 and April 2010.
Program director for basic teaching in paediatrics for medical students including examination, Umeå University, Feb -Aug 2000 and ongoing from 1st Febr 2005 until July 2009.
Group tutor in Problem based learning in paediatrics, Umeå University, 2 hrs/week during 2000 and ongoing from 1st Febr 2005.
Invited speaker in a 3 day research course on Evidence Based Medicine, Inst of Womens and Childrens health/Ob-gyn, The Sahlgrenska Academy at Göteborg University, 2004 - 2007.
Invited speaker in a 3 day specialist training course on ‘Fertility problems’, Inst of Obstetrics and Gynecology, Umeå Universityhospital 2006 - 2007.
Program director for a yearly 3 day national course in pediatric endocrinology for Pediatric teams (pediatricians and pediatric nurses) in 2002 – 2009.
Group tutor in paediatric endocrinology (case methodology), The Sahlgrenska Academy at Göteborg University, 2000-2004.
Lecturer in paediatric endocrinology for medical students, postgraduate paediatricians and dentist doctors, nurses etc. since 1991.
Participated in a co-ordinating group for teaching in endocrinology during the 5,5 years of medical training for medical students in Umeå.

Main Research Supervisor
Elena Lundberg (pediatrician); pediatric endocrinologist MD.
Research project: GH responsiveness in children
(Supervisors: Berit Kriström*, Kerstin Albertsson Wikland)

Associate research Supervisor
1. Maria Forsner, Reg nurse, PhD 20061215
Thesis: Att vara barn i sjukdom och sjukvård: barns berättelser om sina upplevelser av sjukdom och sjukvårdsrädsla
2. Anders Nygren (pediatrician; senior fellow in pediatric cardiology) MD. Plan Dissertation 2011.
Research project: Autocrine and endocrine effects in the pediatric heart
(Supervisors: Jan Sunnegårdh*, Berit Kriström, Kerstin Albertsson-Wikland, Jörgen Isgaard)
3. Ralph Decker (pediatric endocrinologist) MD. Plan dissertation 2012.
Research project: Metabolic responsiveness to growth hormone in children.
(Supervisors: Jovanna Dahlgren*, Kerstin Albertsson Wikland, Berit Kriström)

Research:
Genetics and pituitary development
Growth and puberty in GHD/ISS and in Turner syndrome.
Special interest in GH responsiveness and individually adapted doses during GH-treatment in GHD and ISS children. Models for prediction of growth response in GH treatment in children.
Effects on cognition, quality of life and self esteem during GH treatment.
Dissertation 12th May 1999; titled ‘Growth hormone treatment in children - prediction of growth response’. Tutor: Prof K Albertsson Wikland, Göteborg, Sweden. Opponent: Prof JM Wit, Leiden, The Netherlands

Reviewer of journals
Acta Paediatrica
Clinical Endocrinology
Europ J Endocrinol
Growth Hormone & IGF Research
J Clin Endocrinol Metab
Paediatrics

Memberships:
The Swedish Paediatric Society (member of the board 1999-2001).
The Section for Paediatric Endocrinology and Diabetes (member of the board 1997-2003) and chairperson for Swedish National Committee for growth disturbances and GH treatment since 2005
The Swedish Paediatric Study Group for Growth Hormone Treatment since 1991.
Swedish Endocrine Society
Swedish Society of Medicine
Swedish Medical Association
European Society for Pediatric Endocrinology (ESPE) and Board Member for ESPE Turner club
Informationen är tillförlitlig | uppdaterad: 2011-10-23 av Berit Kriström |
Personkort för Berit Kriström, från FoU i Sverige
http://www.fou.nu/is/sverige/user/html/3904